These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential. Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842 [TBL] [Abstract][Full Text] [Related]
4. Ultrasound Promoted Green Synthesis, Docking Study of Indole Spliced Thiadiazole, α-amino Phosphonates as Anticancer Agents and Antityrosinase Agents. Nikalje AG; Gawhane PA; Tiwari SV; Sangshetti JN; Damale MG Anticancer Agents Med Chem; 2018; 18(9):1267-1280. PubMed ID: 29667556 [TBL] [Abstract][Full Text] [Related]
5. N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential. Kamath PR; Sunil D; Ajees AA; Pai KS; Biswas S Eur J Med Chem; 2016 Sep; 120():134-47. PubMed ID: 27187865 [TBL] [Abstract][Full Text] [Related]
6. Development of Novel Triazolo-Thiadiazoles from Heterogeneous "Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors. Baburajeev CP; Dhananjaya Mohan C; Ananda H; Rangappa S; Fuchs JE; Jagadish S; Sivaraman Siveen K; Chinnathambi A; Ali Alharbi S; Zayed ME; Zhang J; Li F; Sethi G; Girish KS; Bender A; Basappa ; Rangappa KS Sci Rep; 2015 Sep; 5():14195. PubMed ID: 26388336 [TBL] [Abstract][Full Text] [Related]
7. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies. Kamath PR; Sunil D; Ajees AA; Pai KS; Das S Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. Kumar D; Maruthi Kumar N; Chang KH; Shah K Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety. Zhao PL; Duan AN; Zou M; Yang HK; You WW; Wu SG Bioorg Med Chem Lett; 2012 Jul; 22(13):4471-4. PubMed ID: 22647723 [TBL] [Abstract][Full Text] [Related]
10. Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. Zhang L; Zhao J; Zhang B; Lu T; Chen Y Eur J Med Chem; 2018 Apr; 150():809-816. PubMed ID: 29602036 [TBL] [Abstract][Full Text] [Related]
11. The new facile and straightforward method for the synthesis of 4H-1,2,3-thiadiazolo[5,4-b]indoles and determination of their antiproliferative activity. Belskaya NP; Lugovik KI; Bakulev VA; Bauer J; Kitanovic I; Holenya P; Zakhartsev M; Wölfl S Eur J Med Chem; 2016 Jan; 108():245-257. PubMed ID: 26686930 [TBL] [Abstract][Full Text] [Related]
12. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione. Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234 [TBL] [Abstract][Full Text] [Related]
13. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function. Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313 [TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells. Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578 [TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity. Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives. Kumar S; Gopalakrishnan V; Hegde M; Rana V; Dhepe SS; Ramareddy SA; Leoni A; Locatelli A; Morigi R; Rambaldi M; Srivastava M; Raghavan SC; Karki SS Bioorg Med Chem Lett; 2014 Oct; 24(19):4682-4688. PubMed ID: 25205189 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones. Mohamed MF; Hassaneen HM; Abdelhamid IA Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336 [TBL] [Abstract][Full Text] [Related]
18. New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents. Hamdy R; Jones AT; El-Sadek M; Hamoda AM; Shakartalla SB; Al Shareef ZM; Soliman SSM; Westwell AD Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830153 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents. Altıntop MD; Sever B; Özdemir A; Ilgın S; Atlı Ö; Turan-Zitouni G; Kaplancıklı ZA Anticancer Agents Med Chem; 2018; 18(11):1606-1616. PubMed ID: 29745341 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole. Wu J; Li J; Xu MH; Liu D Bioorg Med Chem Lett; 2014 Jul; 24(14):3050-6. PubMed ID: 24880902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]